BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17204333)

  • 21. Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy.
    Matzner U; Matthes F; Herbst E; Lüllmann-Rauch R; Callaerts-Vegh Z; D'Hooge R; Weigelt C; Eistrup C; Fogh J; Gieselmann V
    Mol Med; 2007; 13(9-10):471-9. PubMed ID: 17660863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy.
    Stroobants S; Leroy T; Eckhardt M; Aerts JM; Berckmans D; D'Hooge R
    Behav Brain Res; 2008 Jun; 189(2):306-16. PubMed ID: 18336930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulfatide storage in visceral organs of arylsulfatase A-deficient mice.
    Schott I; Hartmann D; Gieselmann V; Lüllmann-Rauch R
    Virchows Arch; 2001 Jul; 439(1):90-6. PubMed ID: 11499846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.
    Eckhardt M; Hedayati KK; Pitsch J; Lüllmann-Rauch R; Beck H; Fewou SN; Gieselmann V
    J Neurosci; 2007 Aug; 27(34):9009-21. PubMed ID: 17715338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful transduction of oligodendrocytes and restoration of arylsulfatase A deficiency in metachromatic leukodystrophy fibroblasts using an adenovirus vector.
    Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Eto Y
    Gene Ther; 1995 Sep; 2(7):443-9. PubMed ID: 7584122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
    Blomqvist M; Gieselmann V; Månsson JE
    Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfatide with short fatty acid dominates in astrocytes and neurons.
    Isaac G; Pernber Z; Gieselmann V; Hansson E; Bergquist J; Månsson JE
    FEBS J; 2006 Apr; 273(8):1782-90. PubMed ID: 16623713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology.
    Hohenschutz C; Friedl W; Schlör KH; Waheed A; Conzelmann E; Sandhoff K; Propping P
    Am J Med Genet; 1988 Sep; 31(1):169-75. PubMed ID: 2906225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice.
    Molander-Melin M; Pernber Z; Franken S; Gieselmann V; Månsson JE; Fredman P
    J Neurocytol; 2004 Jul; 33(4):417-27. PubMed ID: 15520527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telencephalic histopathology and changes in behavioural and neural plasticity in a murine model for metachromatic leukodystrophy.
    Faldini E; Stroobants S; Lüllmann-Rauch R; Eckhardt M; Gieselmann V; Balschun D; D'Hooge R
    Behav Brain Res; 2011 Sep; 222(2):309-14. PubMed ID: 21459117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.
    Matzner U; Breiden B; Schwarzmann G; Yaghootfam A; Fluharty AL; Hasilik A; Sandhoff K; Gieselmann V
    J Biol Chem; 2009 Apr; 284(14):9372-81. PubMed ID: 19224915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metachromatic leukodystrophy without arylsulfatase A deficiency.
    Shapiro LJ; Aleck KA; Kaback MM; Itabashi H; Desnick RJ; Brand N; Stevens RL; Fluharty AL; Kihara H
    Pediatr Res; 1979 Oct; 13(10):1179-81. PubMed ID: 41211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
    Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
    Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of arylsulfatase A gene in fibroblasts from metachromatic leukodystrophy patients does not induce a new phenotype.
    Ohashi T; Matalon R; Barranger JA; Eto Y
    Gene Ther; 1995 Aug; 2(6):363-8. PubMed ID: 7584110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
    Kurai T; Hisayasu S; Kitagawa R; Migita M; Suzuki H; Hirai Y; Shimada T
    Mol Ther; 2007 Jan; 15(1):38-43. PubMed ID: 17164773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannose 6-phosphate receptor-dependent endocytosis of lysosomal enzymes is increased in sulfatide-storing kidney cells.
    Klein D; Yaghootfam A; Matzner U; Koch B; Braulke T; Gieselmann V
    Biol Chem; 2009 Jan; 390(1):41-8. PubMed ID: 19007310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene.
    Marcão AM; Wiest R; Schindler K; Wiesmann U; Weis J; Schroth G; Miranda MC; Sturzenegger M; Gieselmann V
    Arch Neurol; 2005 Feb; 62(2):309-13. PubMed ID: 15710861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
    Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
    J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delay of myelin formation in arylsulphatase A-deficient mice.
    Yaghootfam A; Gieselmann V; Eckhardt M
    Eur J Neurosci; 2005 Feb; 21(3):711-20. PubMed ID: 15733089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olaparib Attenuates Demyelination and Neuroinflammation in an Organotypic Slice Culture Model of Metachromatic Leukodystrophy.
    Mekhaeil M; Conroy MJ; Dev KK
    Neurotherapeutics; 2023 Sep; 20(5):1347-1368. PubMed ID: 37525026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.